Achromobacter xylosoxidans: Characterization of strains in Brazilian cystic fibrosis patients

Journal of Clinical Microbiology

Volumn 49, Issue 10, 2011, Pages 3649-3651

  Pereira, Rosana H V ^a   Carvalho Assef, Ana Paula ^d   Albano, Rodolpho M ^b   Folescu, Tania W ^d   Jones, Marcia C M F ^a   Leão, Robson S ^a   Marques, Elizabeth A ^a,c  

^a UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENOMIC DNA; RNA 16S;

ACHROMOBACTER XYLOSOXIDANS; ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BODY MASS; BRAZILIAN; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CROSS INFECTION; CYSTIC FIBROSIS; DISEASE TRANSMISSION; DNA SEQUENCE; ETHNIC GROUP; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; LONG TERM CARE; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; RACE DIFFERENCE; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE;

ACHROMOBACTER DENITRIFICANS; ADOLESCENT; ADULT; BRAZIL; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CROSS INFECTION; CYSTIC FIBROSIS; DNA, BACTERIAL; FEMALE; GENOTYPE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; POLYMORPHISM, GENETIC; YOUNG ADULT;

ACHROMOBACTER XYLOSOXIDANS;

EID: 80053480074     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05283-11     Document Type: Article

References (19)

1. Barth, A. L., et al. 2007. Cystic fibrosis patient with Burkholderia pseudomallei infection acquired in Brazil. J. Clin. Microbiol. 45:4077-4080. (Pubitemid 350274902)
2. De Baets, F., P. Schelstraete, S. Van Daele, F. Haerynck, and M. Vaneechoutte. 2007. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros. 6:75-78. (Pubitemid 46029892)
3. Emerson, J., S. McNamara, A. M. Buccat, K. Worrell, and J. L. Burns. 2010. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatr. Pulmonol. 45:363-370.
4. Gilligan, P. H., D. L. Kiska, and M. D. Appleman. 2006. Cumitech 43, Cystic fibrosis microbiology. Coordinating ed., M. D. Appleman. ASM Press, Washington, DC.
5. Hauser, A. R., M. Jain, M. Bar-Meir, and S. A. McColley. 2011. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin. Microbiol. Rev. 24:29-70.
6. Hirashi, A. 1992. Direct automated sequencing of 16s rDNA amplified by polymerase chain reaction from bacterial cultures without DNA purification. Lett. Appl. Microbiol. 15:210-213.
7. Kanellopoulou, M., et al. 2004. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur. J. Clin. Microbiol. Infect. Dis. 23:336-339. (Pubitemid 38669944)
8. Lambiase, A., et al. 2011. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 30:973-980.
9. Leão, R S., et al. 2010. Comparison of the worldwide transmissible Pseudomonas aeruginosa with isolates from Brazilian cystic fibrosis patients. Braz. J. Microbiol. 41:1079-1081.
10. Leão, R. S., et al. 2010. First report of Paenibacillus cineris from a patient with cystic fibrosis. Diagn. Microbiol. Infect. Dis. 66:101-103.
11. Liu, L., et al. 2002. Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J. Clin. Microbiol. 40:1210-1213. (Pubitemid 34279877)
12. Magni, A., M., et al. 2010. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features of cystic fibrosis patients. J. Clin. Microbiol. 48:1035-1039.
13. Moissenet, D., et al. 1997. Colonization by Acaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin. Infect. Dis. 24:274-275. (Pubitemid 27081560)
14. Peltroche-Llacshuanga, H., H. Kentrup, and G. Haase. 1998. Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 17:132-134. (Pubitemid 28306126)
15. Raso, T., O. Bianco, B. Grosso, M. Zucca, and D. Savoia. 2008. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS 116:837-841.
16. Rønne Hansen, C., T. Pressler, N. Høiby, and M. Gormsen. 2006. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. J. Cyst. Fibros. 5:245-251. (Pubitemid 44824860)
17. Saiman, L. 2011. Infection prevention and control in cystic fibrosis. Curr. Opin. Infect. Dis. 24:390-395.
18. Turton J. F., et al. 2011. Identification of Achromobacter xylosoxidans by detection of the bla(OXA-114-like) gene intrinsic in this species. Diagn. Microbiol. Infect. Dis. 70:408-411.
19. Van Daele, S., et al. 2005. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center. J. Clin. Microbiol. 43:2998-3002. (Pubitemid 40827999)